Showing results (631-640 of 640) with videos related to
Sort By:
Pageof 64
You have reached the last page of results.This site can display upto 640 results.
JAMA Cardiology|September 28, 2022
Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical TrialKi Hong Choi, Yong Hwan Park, Young Bin Song, et al.JACC. Asia|November 7, 2022
Differential Long-Term Effects of First- and Second-Generation DES in Patients With Bifurcation Lesions Undergoing PCIKi Hong Choi, Young Bin Song, Joo Myung Lee, et al.Circulation. Cardiovascular Interventions|February 19, 2020
Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting StentKi Hong Choi, Young Bin Song, Joo Myung Lee, et al.Journal of the American Heart Association|December 21, 2020
Safety of 3-Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus-Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART-CHOICE TrialKyeong Ho Yun, Seung-Yul Lee, Byung Ryul Cho, et al.Heart (British Cardiac Society)|March 24, 2021
P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitorJuwon Kim, Woo Jin Jang, Wang Soo Lee, et al.International Journal of Cardiology|August 11, 2018
Comparison of long-term clinical outcomes between revascularization versus medical treatment in patients with silent myocardial ischemiaKi Hong Choi, Joo Myung Lee, Il Park, et al.Cardiology Journal|September 15, 2021
P2Y12 inhibitor monotherapy in complex percutaneous coronary intervention: A post-hoc analysis of SMART-CHOICE randomized clinical trialJi Woong Roh, Joo-Yong Hahn, Ju-Hyeon Oh, et al.Journal of the American Heart Association|September 13, 2021
Ten-Year Trends in Coronary Bifurcation Percutaneous Coronary Intervention: Prognostic Effects of Patient and Lesion Characteristics, Devices, and TechniquesJoo Myung Lee, Seung Hun Lee, Juwon Kim, et al.Clinical Therapeutics|May 4, 2024
The Efficacy and Tolerability of Irbesartan/Amlodipine Combination Therapy in Patients With Essential Hypertension Whose Blood Pressure Were not Controlled by Irbesartan MonotherapyHae-Young Lee, Kyung Wan Min, Kyung Ah Han, et al.Annals of Coloproctology|May 7, 2024
Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatmentHyo Seon Ryu, Hyun Jung Kim, Woong Bae Ji, et al.Pageof 64